News
NYXH
0.8715
-1.85%
-0.0164
Nyxoah Sets Date for Q3 2026 Results as Genio Sleep Apnea Therapy Scales Globally
TipRanks · 5d ago
Weekly Report: what happened at NYXH last week (1019-1023)?
Weekly Report · 5d ago
Why RingCentral Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/23 08:34
Analysts Have Conflicting Sentiments on These Healthcare Companies: EyePoint Pharmaceuticals (EYPT) and Nyxoah (NYXH)
TipRanks · 10/21 06:40
Nyxoah Cuts 2026 Revenue Guidance as U.S. Sales and CCC Data Drive Q3 Surge
TipRanks · 10/20 20:55
Here's Why Nyxoah (NYXH) Could be Great Choice for a Bottom Fisher
NASDAQ · 10/20 12:55
Nyxoah Cuts 2026 Revenue Guidance as U.S. Genio Sales Accelerate
TipRanks · 10/19 13:17
Morning Movers: Cleveland-Cliffs surges following third quarter earnings report
TipRanks · 10/19 13:00
Nyxoah reports preliminary Q3 revenue EUR 9.2M, consensus EUR 9.93M
TipRanks · 10/19 12:15
Nyxoah cuts FY26 revenue view to EUR 33M-EUR 35M from EUR 36M-EUR 40M
TipRanks · 10/19 12:15
Nyxoah Reports Preliminary Q3 Global Net Sales Of ~€9.2M, Up 19% QoQ; Lowers FY26 Global Net Sales From €36M-€40M To €33M-€35M
Benzinga · 10/19 12:05
Weekly Report: what happened at NYXH last week (1012-1016)?
Weekly Report · 10/19 09:45
Nyxoah’s Genio Device Shows Strong 12-Month Results in U.S. Sleep Apnea Trial
TipRanks · 10/15 20:39
Nyxoah presents complete ACCCESS U.S. study data, submits PMA supplement to FDA
TipRanks · 10/15 20:18
Weekly Report: what happened at NYXH last week (1005-1009)?
Weekly Report · 10/12 09:47
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
NASDAQ · 10/06 10:38
Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.
Seeking Alpha · 10/05 11:21
Weekly Report: what happened at NYXH last week (0928-1002)?
Weekly Report · 10/05 09:47
Nyxoah Names Liam Kelly As Chief Executive Officer; Stock Down
NASDAQ · 09/29 10:16
Nyxoah Taps Former Teleflex Chief Liam Kelly to Lead U.S.-Focused Growth Drive
TipRanks · 09/28 21:18
More
Webull provides a variety of real-time NYXH stock news. You can receive the latest news about NYXOAH S A through multiple platforms. This information may help you make smarter investment decisions.
About NYXH
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.